COVID vaccine maker Novavax forecasts higher-than-expected revenue Ruchika Sharma11 May 2023 10:15 AM ISTUnited States: COVID-19 vaccine maker Novavax Inc on Tuesday forecast much higher 2023 revenue than Wall Street expected and announced plans to cut a...
Novavax lays off 25 percent of workforce Ruchika Sharma10 May 2023 1:30 PM ISTUnited States: Novavax said on Tuesday it will reduce its global workforce by 25% as the cash-strapped biotech pushes forward with its plans to slash...
Novavax cut USD 50 million in costs, plans to slash more: CEO Ruchika Sharma15 April 2023 2:00 PM ISTUnited States: Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive John Jacobs said in an...
Novavax ropes in John C Jacobs as new CEO, President Ruchika Sharma10 Jan 2023 1:30 PM ISTGaithersburg: Novavax, Inc., a biotechnology company has announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief...
Novavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccines Ruchika Sharma1 Jan 2023 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax Nuvaxovid COVID vaccine approved in Canada for use as primary series in adolescents Ruchika Sharma8 Dec 2022 10:15 AM ISTGaithersburg: Novavax, Inc. has announced that Health Canada has approved a supplement to a New Drug Submission (sNDS) for Nuvaxovid (COVID-19 Vaccine...
Novavax claim on COVID vaccine deal breach rejected by Gavi Ruchika Sharma25 Nov 2022 2:30 PM ISTIn response to Gavi's statement, Novavax reiterated that it has been ready to meet its commitment to manufacture and deliver doses for the COVAX...
Novavax appoints Rick Rodgers as new Independent director Ruchika Sharma5 Nov 2022 4:06 PM ISTGaithersburg: Novavax, Inc. has announced the appointment of Richard Rodgers, MBA to its board as an independent director. Mr. Rodgers brings...
USFDA grants emergency use nod for Novavax COVID vaccine,Adjuvanted as booster for adults Ruchika Sharma20 Oct 2022 5:46 PM ISTGaithersburg: Novavax, Inc. has announced that the company's COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA)...
Novavax seeks updated Emergency Use Listing from WHO for Nuvaxovid as booster in adults Ruchika Sharma18 Sept 2022 12:30 PM ISTUS: Novavax has announced the submission of a request to the World Health Organization (WHO) to update the Emergency Use Listing (EUL) of Nuvaxovid...
Novavax Nuvaxovid gets expanded conditional marketing authorization in EU for use as booster for adults aged 18 and older Ruchika Sharma14 Sept 2022 1:15 PM ISTGaithersburg: Biotechnology company, Novavax, Inc., has recently announced that the European Commission (EC) has approved the expanded conditional...
SII, Novavax report full product registration in South Africa of COVID jab NVX-CoV2373 for adults aged 18 and older Ruchika Sharma14 Sept 2022 12:20 PM ISTGaithersburg: Novavax, Inc., a biotechnology company and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by...
